CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...